课题基金 / 基金详情

I: Penn State Institutional Career Development Core

I: Penn State Institutional Career Development Core
I:宾夕法尼亚州立大学机构职业发展核心
批准号:
10670912
负责人:
Lauren Jodi Van Scoy
金额:
$59.82万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-09-15 至 2026-06-30

项目摘要

项目成果

Lauren Jodi Van Scoy的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT-PENN STATE INSTITUTIONAL CAREER DEVELOPMENT CORE Advances in the efficiency, quality and impact of clinical and translational science (CTS) research will be achieved by researchers who are trained in rigorous research methodologies and equipped to navigate a pathway from basic discovery to improved health. The overall goal of the Penn State Clinical and Translational Science lnstitute's (CTSI) Institutional Career Development Program is to accelerate scholar transition to research independence. Our priorities include increasing the racial, ethnic, and scientific diversity of our scholars, utilizing innovative strategies to engage and guide scholars to enhance research productivity, extending engagement in rural health research, and refining our data-driven continuous programmatic improvement. We will recruit KL2 scholars with outstanding potential to become catalysts for innovation in biomedical research translation. In this application we request support for 4 KL2 scholars and have an institutional commitment for an additional 4 scholars. All grant-funded and institutionally funded scholars will be selected through a University-wide RFA, have access to the same career development opportunities, and same expectations for progress toward development of scientific independence. The selected scholars will be enrolled in an intensive 3-year program designed to prepare the next generation of leaders in CTS. Our Aims are to: 1. Recruit and engage talented scholars from diverse backgrounds in collaborative clinical and translational sciences (CTS) career development. 2. Implement an intensive mentoring/coaching strategy for current and recent scholars to "turn the curve" on scholar transition to independence. 3. Leverage the strengths of our CTSl's rural environment, partnerships and technologies to develop a CTS research practicum in rural health. 4. Refine processes for collection, analysis and utilization of evaluative data guided by the logic model to foster continuous quality improvement of the career development program. We recognize multiple factors contribute to the scholars' transition to independence, including their initiative, persistence, resilience, supportive mentorship, interactions with collaborators, protected research time, and the institutional research infrastructure and culture. Timing for milestones on the path toward independence also varies depending on each individual's prior training. Our programmatic offerings are coordinated with the Translational Endeavors Core, the Community Engaged Research Core (CERC) and the TL 1 program, and include advanced degrees, core seminars, experiential opportunities, individual courses, learning modules, and flexibility for individualized learning. Intended outcomes are competent translational researchers with skills to accelerate discovery by bridging gaps and innovation along the translational research continuum.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1210/jcemcr/luad103
发表时间: 2023-09
期刊: JCEM case reports
影响因子: --
作者: []
通讯作者:
DOI: 10.1177/17455057231219601
发表时间: 2023-01
期刊: WOMENS HEALTH
影响因子: 2.4
作者: [Horvath, Sarah, Frietsche, Susan]
通讯作者: Frietsche, Susan
Chronic Generalized Lymphadenopathy in a Child-Progressive Transformation of Germinal Centers (PTGC).
生发中心儿童促进转化(PTGC)的慢性广义淋巴结肿大。
DOI: 10.3390/children9020214
发表时间: 2022-02-06
期刊: Children (Basel, Switzerland)
影响因子: --
作者: [Wills C, Mercer K, Malysz J, Rivera Galvis L, Gowda C]
通讯作者: Gowda C
DOI: 10.1097/inf.0000000000002663
发表时间: 2020-08
期刊: The Pediatric infectious disease journal
影响因子: --
作者: [Ericson JE, Hornik CP, Greenberg RG, Clark RH, Tremoulet AH, Le J, Cohen-Wolkowiez M, Smith PB, Benjamin DK Jr, Best Pharmaceuticals for Children Act – Pediatric Trials Network]
通讯作者: Best Pharmaceuticals for Children Act – Pediatric Trials Network
6
    Engaging underserved communities in end-of-life conversations: a cluster, randomized controlled trial
    Engaging underserved communities in end-of-life conversations: a cluster, randomized controlled trial
    海外基金